Richard Price, MD

Title(s)Professor Emeritus, Neurology
SchoolSchool of Medicine
Address1001 Potrero Ave
San Francisco CA 94110
vCardDownload vCard
    Other Positions
    Title(s)UCSF Weill Institute for Neurosciences

    Collapse Research 
    Collapse Research Activities and Funding
    Compartmentalized CSF viral escape and the CNS HIV reservoir
    NIH R01NS094067Sep 30, 2015 - Jul 31, 2021
    Role: Principal Investigator
    Defining CNS HIV Infection in Treated Patients: Foundation for Eradication
    NIH R21MH096619Jan 11, 2012 - Dec 31, 2014
    Role: Principal Investigator
    HIV Tropism, Persistence, Inflammation and Neurocognition in Therapy Initiation
    NIH P01MH094177Aug 22, 2011 - May 31, 2016
    Role: Co-Investigator
    Central Nervous System HIV Translational Research Training Program
    NIH T32MH090847Jun 1, 2010 - May 31, 2015
    Role: Principal Investigator
    HIV Proteomic Center for Host-Viral Response Characterization
    NIH P01DA026134Sep 30, 2008 - May 31, 2012
    Role: Co-Investigator
    The Neuropathobiology of Primary HIV-1 Infection
    NIH R01MH081772Sep 1, 2008 - Jan 31, 2015
    Role: Co-Principal Investigator
    Pilot Study of Treatment Augmentation on CNS Immunoactivation in Treated HIV-1 In
    NIH R21MH083520Apr 1, 2008 - Jul 31, 2011
    Role: Principal Investigator
    CSF Molecular Marker Study Consortium
    NIH R01NS043103Feb 15, 2002 - Jan 31, 2008
    Role: Principal Investigator
    CSF &Lymphocyte Dynamics in HIV Infection
    NIH R01MH062701Sep 30, 2000 - Nov 30, 2011
    Role: Principal Investigator
    Treatment&Pathogenesis of Cerebrospinal Fluid HIV Infect
    NIH R01NS037660May 15, 1998 - Apr 30, 2006
    Role: Principal Investigator
    NIH P01NS033718Jan 1, 1995 - Dec 31, 2000
    Role: Co-Investigator
    NIH R10MH052913Sep 1, 1994 - Aug 31, 2000
    Role: Principal Investigator
    NIH R01NS032228Dec 1, 1993 - Jul 31, 2003
    Role: Co-Investigator
    NIH R13NS031341Nov 15, 1992 - Nov 14, 1993
    Role: Principal Investigator
    NIH P30MH038330Dec 1, 1989 - Aug 31, 2004
    Role: Principal Investigator
    NIH P01NS025701Feb 1, 1988 - Jan 31, 1999
    Role: Co-Principal Investigator
    NIH R01NS021703Dec 1, 1985 - Nov 30, 1988
    Role: Principal Investigator
    NIH P50MH038330Sep 15, 1983 - Nov 30, 1994
    Role: Principal Investigator
    Drug Abuse Treatment System Survey
    NIH R01DA003272Mar 1, 1983 - Apr 30, 2008
    Role: Co-Principal Investigator
    NIH R01NS019048Jan 1, 1983 - Jun 30, 1989
    Role: Principal Investigator
    General Clinical Research Center
    NIH M01RR000083Oct 1, 1974 - Nov 30, 2007
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Global Health
    Collapse Academic Senate

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Neurochemical biomarkers to study CNS effects of COVID-19: a narrative review and synthesis. J Neurochem. 2021 Jun 25. Edén A, Simrén J, Price RW, Zetterberg H, Gisslén M. PMID: 34170549.
      View in: PubMed   Mentions:    Fields:    
    2. Cerebrospinal Fluid and Plasma Lipopolysaccharide Levels in Human Immunodeficiency Virus Type 1 Infection and Associations With Inflammation, Blood-Brain Barrier Permeability, and Neuronal Injury. J Infect Dis. 2021 May 20; 223(9):1612-1620. Jiang W, Luo Z, Stephenson S, Li H, Di Germanio C, Norris PJ, Fuchs D, Zetterberg H, Gisslen M, Price RW. PMID: 33320240.
      View in: PubMed   Mentions: 2     Fields:    
    3. Compartmentalization of cerebrospinal fluid inflammation across the spectrum of untreated HIV-1 infection, central nervous system injury and viral suppression. PLoS One. 2021; 16(5):e0250987. Gisslen M, Keating SM, Spudich S, Arechiga V, Stephenson S, Zetterberg H, Di Germanio C, Blennow K, Fuchs D, Hagberg L, Norris PJ, Peterson J, Shacklett BL, Yiannoutsos CT, Price RW. PMID: 33983973.
      View in: PubMed   Mentions:    Fields:    
    4. CSF Biomarkers in Patients With COVID-19 and Neurologic Symptoms: A Case Series. Neurology. 2021 01 12; 96(2):e294-e300. Edén A, Kanberg N, Gostner J, Fuchs D, Hagberg L, Andersson LM, Lindh M, Price RW, Zetterberg H, Gisslén M. PMID: 33004602.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    5. Herpes zoster in HIV-1 infection: The role of CSF pleocytosis in secondary CSF escape and discordance. PLoS One. 2020; 15(7):e0236162. Hagberg L, Price RW, Zetterberg H, Fuchs D, Gisslén M. PMID: 32697807.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    6. Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19. Neurology. 2020 09 22; 95(12):e1754-e1759. Kanberg N, Ashton NJ, Andersson LM, Yilmaz A, Lindh M, Nilsson S, Price RW, Blennow K, Zetterberg H, Gisslén M. PMID: 32546655.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansCellsPHPublic Health
    7. Cerebrospinal fluid soluble CD30 elevation despite suppressive antiretroviral therapy in individuals living with HIV-1. J Virus Erad. 2020 Feb 20; 6(1):19-26. Peluso MJ, Thanh C, Prator CA, Hogan LE, Arechiga VM, Stephenson S, Norris PJ, Di Germanio C, Fuchs D, Zetterberg H, Deeks SG, Gisslén M, Price RW, Henrich TJ. PMID: 32175087.
      View in: PubMed   Mentions:
    8. Exosomal MicroRNAs Associate With Neuropsychological Performance in Individuals With HIV Infection on Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2019 12 15; 82(5):514-522. O'Meara T, Kong Y, Chiarella J, Price RW, Chaudhury R, Liu X, Spudich S, Robertson K, Emu B, Lu L. PMID: 31714431.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    9. Plasma concentration of neurofilament light chain protein decreases after switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarate. PLoS One. 2019; 14(12):e0226276. Hermansson L, Yilmaz A, Price RW, Nilsson S, McCallister S, Makadzange T, Das M, Zetterberg H, Blennow K, Gisslen M. PMID: 31826005.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    10. Potential for early antiretroviral therapy to reduce central nervous system HIV-1 persistence. AIDS. 2019 12 01; 33 Suppl 2:S135-S144. Spudich S, Peterson J, Fuchs D, Price RW, Gisslen M. PMID: 31789814.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    11. Defining cerebrospinal fluid HIV RNA escape: editorial review AIDS. AIDS. 2019 12 01; 33 Suppl 2:S107-S111. Winston A, Antinori A, Cinque P, Fox HS, Gisslen M, Henrich TJ, Letendre S, Persaud D, Price RW, Spudich S. PMID: 31790376.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    12. What can characterization of cerebrospinal fluid escape populations teach us about viral reservoirs in the central nervous system? AIDS. 2019 12 01; 33 Suppl 2:S171-S179. Joseph SB, Trunfio M, Kincer LP, Calcagno A, Price RW. PMID: 31790378.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    13. Human Immunodeficiency Virus Type 1 RNA Detected in the Central Nervous System (CNS) After Years of Suppressive Antiretroviral Therapy Can Originate from a Replicating CNS Reservoir or Clonally Expanded Cells. Clin Infect Dis. 2019 09 27; 69(8):1345-1352. Joseph SB, Kincer LP, Bowman NM, Evans C, Vinikoor MJ, Lippincott CK, Gisslén M, Spudich S, Menezes P, Robertson K, Archin N, Kashuba A, Eron JJ, Price RW, Swanstrom R. PMID: 30561541.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    14. Predicting Efavirenz Concentrations in the Brain Tissue of HIV-Infected Individuals and Exploring their Relationship to Neurocognitive Impairment. Clin Transl Sci. 2019 05; 12(3):302-311. Srinivas N, Joseph SB, Robertson K, Kincer LP, Menezes P, Adamson L, Schauer AP, Blake KH, White N, Sykes C, Luciw P, Eron JJ, Forrest A, Price RW, Spudich S, Swanstrom R, Kashuba ADM. PMID: 30675981.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCTClinical Trials
    15. Cerebrospinal Fluid Concentrations of the Synaptic Marker Neurogranin in Neuro-HIV and Other Neurological Disorders. Curr HIV/AIDS Rep. 2019 02; 16(1):76-81. Yilmaz A, Fuchs D, Price RW, Spudich S, Blennow K, Zetterberg H, Gisslén M. PMID: 30649659.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    16. Elevated cerebrospinal fluid Galectin-9 is associated with central nervous system immune activation and poor cognitive performance in older HIV-infected individuals. J Neurovirol. 2019 04; 25(2):150-161. Premeaux TA, D'Antoni ML, Abdel-Mohsen M, Pillai SK, Kallianpur KJ, Nakamoto BK, Agsalda-Garcia M, Shiramizu B, Shikuma CM, Gisslén M, Price RW, Valcour V, Ndhlovu LC. PMID: 30478799.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    17. Longitudinal Trajectories of Brain Volume and Cortical Thickness in Treated and Untreated Primary Human Immunodeficiency Virus Infection. Clin Infect Dis. 2018 11 13; 67(11):1697-1704. Sanford R, Ances BM, Meyerhoff DJ, Price RW, Fuchs D, Zetterberg H, Spudich S, Collins DL. PMID: 29697762.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    18. CSF concentrations of soluble TREM2 as a marker of microglial activation in HIV-1 infection. Neurol Neuroimmunol Neuroinflamm. 2019 01; 6(1):e512. Gisslén M, Heslegrave A, Veleva E, Yilmaz A, Andersson LM, Hagberg L, Spudich S, Fuchs D, Price RW, Zetterberg H. PMID: 30568991.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    19. Large Differences in Small RNA Composition Between Human Biofluids. Cell Rep. 2018 10 30; 25(5):1346-1358. Godoy PM, Bhakta NR, Barczak AJ, Cakmak H, Fisher S, MacKenzie TC, Patel T, Price RW, Smith JF, Woodruff PG, Erle DJ. PMID: 30380423.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    20. Single-cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid during virologically suppressed HIV. JCI Insight. 2018 09 20; 3(18). Farhadian SF, Mehta SS, Zografou C, Robertson K, Price RW, Pappalardo J, Chiarella J, Hafler DA, Spudich SS. PMID: 30232286.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    21. Brain MRI Features of CSF Human Immunodeficiency Virus Escape. J Neuroimaging. 2018 11; 28(6):601-607. Narvid J, Callen A, Talbott J, Uzelac A, Dupont SM, Chow F, Price RW, Rehani B. PMID: 30079471.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    22. No neurocognitive advantage for immediate antiretroviral treatment in adults with greater than 500 CD4+ T-cell counts. AIDS. 2018 05 15; 32(8):985-997. Wright EJ, Grund B, Robertson KR, Cysique L, Brew BJ, Collins GL, Poehlman-Roediger M, Vjecha MJ, Penalva de Oliveira AC, Standridge B, Carey C, Avihingsanon A, Florence E, Lundgren JD, Arenas-Pinto A, Mueller NJ, Winston A, Nsubuga MS, Lal L, Price RW, INSIGHT START Neurology Substudy Group . PMID: 29424786.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    23. Anti-Human Immunodeficiency Virus Antibodies in the Cerebrospinal Fluid: Evidence of Early Treatment Impact on Central Nervous System Reservoir? J Infect Dis. 2018 03 13; 217(7):1024-1032. Burbelo PD, Price RW, Hagberg L, Hatano H, Spudich S, Deeks SG, Gisslén M. PMID: 29401308.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    24. HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study. PLoS Med. 2017 Nov; 14(11):e1002417. Henrich TJ, Hatano H, Bacon O, Hogan LE, Rutishauser R, Hill A, Kearney MF, Anderson EM, Buchbinder SP, Cohen SE, Abdel-Mohsen M, Pohlmeyer CW, Fromentin R, Hoh R, Liu AY, McCune JM, Spindler J, Metcalf-Pate K, Hobbs KS, Thanh C, Gibson EA, Kuritzkes DR, Siliciano RF, Price RW, Richman DD, Chomont N, Siliciano JD, Mellors JW, Yukl SA, Blankson JN, Liegler T, Deeks SG. PMID: 29112956.
      View in: PubMed   Mentions: 83     Fields:    Translation:HumansCellsPHPublic Health
    25. Neurofilament light chain protein as a marker of neuronal injury: review of its use in HIV-1 infection and reference values for HIV-negative controls. Expert Rev Mol Diagn. 2017 08; 17(8):761-770. Yilmaz A, Blennow K, Hagberg L, Nilsson S, Price RW, Schouten J, Spudich S, Underwood J, Zetterberg H, Gisslén M. PMID: 28598205.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    26. Blood-Brain Barrier Disruption Is Initiated During Primary HIV Infection and Not Rapidly Altered by Antiretroviral Therapy. J Infect Dis. 2017 04 01; 215(7):1132-1140. Rahimy E, Li FY, Hagberg L, Fuchs D, Robertson K, Meyerhoff DJ, Zetterberg H, Price RW, Gisslén M, Spudich S. PMID: 28368497.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    27. Greater Risk of Stroke of Undetermined Etiology in a Contemporary HIV-Infected Cohort Compared with Uninfected Individuals. J Stroke Cerebrovasc Dis. 2017 May; 26(5):1154-1160. Chow FC, Price RW, Hsue PY, Kim AS. PMID: 28262563.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    28. Relationship Between HIV Infection, Antiretroviral Therapy, Inflammatory Markers, and Cerebrovascular Endothelial Function Among Adults in Urban China. . 2017 03 01; 74(3):339-346. Chow FC, Li Y, Hu Y, Chan J, Wang H, Xu W, Price RW, Sorond FA, Li T. PMID: 27875362.
      View in: PubMed   Mentions:
    29. Blood-brain barrier integrity, intrathecal immunoactivation, and neuronal injury in HIV. Neurol Neuroimmunol Neuroinflamm. 2016 Dec; 3(6):e300. Anesten B, Yilmaz A, Hagberg L, Zetterberg H, Nilsson S, Brew BJ, Fuchs D, Price RW, Gisslén M. PMID: 27868081.
      View in: PubMed   Mentions: 12     Fields:    
    30. Highlights of the Global HIV-1 CSF Escape Consortium Meeting, 9 June 2016, Bethesda, MD, USA. J Virus Erad. 2016 Oct 05; 2(4):243-250. Joseph J, Cinque P, Colosi D, Dravid A, Ene L, Fox H, Gabuzda D, Gisslen M, Beth Joseph S, Letendre S, Mukerji SS, Nath A, Perez-Valero I, Persaud D, Price RW, Rao VR, Sacktor N, Swanstrom R, Winston A, Wojna V, Wright E, Spudich S. PMID: 27781109.
      View in: PubMed   Mentions:
    31. No support for premature central nervous system aging in HIV-1 when measured by cerebrospinal fluid phosphorylated tau (p-tau). Virulence. 2017 07 04; 8(5):599-604. Krut JJ, Price RW, Zetterberg H, Fuchs D, Hagberg L, Yilmaz A, Cinque P, Nilsson S, Gisslén M. PMID: 27435879.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    32. Putamen volume and its clinical and neurological correlates in primary HIV infection. AIDS. 2016 07 17; 30(11):1789-94. Wright PW, Pyakurel A, Vaida FF, Price RW, Lee E, Peterson J, Fuchs D, Zetterberg H, Robertson KR, Walter R, Meyerhoff DJ, Spudich SS, Ances BM. PMID: 27045376.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    33. Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment. PLoS One. 2016; 11(6):e0157160. Edén A, Marcotte TD, Heaton RK, Nilsson S, Zetterberg H, Fuchs D, Franklin D, Price RW, Grant I, Letendre SL, Gisslén M. PMID: 27295036.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    34. Immune Activation and HIV-Specific CD8(+) T Cells in Cerebrospinal Fluid of HIV Controllers and Noncontrollers. AIDS Res Hum Retroviruses. 2016 08; 32(8):791-800. Ganesh A, Lemongello D, Lee E, Peterson J, McLaughlin BE, Ferre AL, Gillespie GM, Fuchs D, Deeks SG, Hunt PW, Price RW, Spudich SS, Shacklett BL. PMID: 27019338.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    35. Corrigendum to: "Plasma concentration of the neurofilament light protein (NFL) is a biomarker of CNS injury in HIV infection: A cross-sectional study" [EBioMedicine 3 (216) 135-140]. EBioMedicine. 2016 05; 7:287-288. Gisslén M, Price RW, Andreasson U, Norgren N, Nilsson S, Hagberg L, Fuchs D, Spudich S, Blennow K, Zetterberg H. PMID: 27322482.
      View in: PubMed   Mentions: 2     Fields:    
    36. Cerebral vasoreactivity is impaired in treated, virally suppressed HIV-infected individuals. AIDS. 2016 Jan 02; 30(1):45-55. Chow FC, Boscardin WJ, Mills C, Ko N, Carroll C, Price RW, Deeks S, Sorond FA, Hsue PY. PMID: 26372478.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    37. Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study. EBioMedicine. 2016 Jan; 3:135-140. Gisslén M, Price RW, Andreasson U, Norgren N, Nilsson S, Hagberg L, Fuchs D, Spudich S, Blennow K, Zetterberg H. PMID: 26870824.
      View in: PubMed   Mentions: 128     Fields:    Translation:Humans
    38. Phenotypic Correlates of HIV-1 Macrophage Tropism. J Virol. 2015 Nov; 89(22):11294-311. Arrildt KT, LaBranche CC, Joseph SB, Dukhovlinova EN, Graham WD, Ping LH, Schnell G, Sturdevant CB, Kincer LP, Mallewa M, Heyderman RS, Rie AV, Cohen MS, Spudich S, Price RW, Montefiori DC, Swanstrom R. PMID: 26339058.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    39. Cerebrospinal Fluid HIV Escape from Antiretroviral Therapy. Curr HIV/AIDS Rep. 2015 Jun; 12(2):280-8. Ferretti F, Gisslen M, Cinque P, Price RW. PMID: 25860317.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCells
    40. Factors associated with neurocognitive test performance at baseline: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. HIV Med. 2015 Apr; 16 Suppl 1:97-108. Wright EJ, Grund B, Cysique LA, Robertson KR, Brew BJ, Collins G, Shlay JC, Winston A, Read TR, Price RW, International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) START Study Group . PMID: 25711328.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    41. Compartmentalized replication of R5 T cell-tropic HIV-1 in the central nervous system early in the course of infection. PLoS Pathog. 2015 Mar; 11(3):e1004720. Sturdevant CB, Joseph SB, Schnell G, Price RW, Swanstrom R, Spudich S. PMID: 25811757.
      View in: PubMed   Mentions: 67     Fields:    Translation:HumansCellsCTClinical Trials
    42. Cerebral white matter integrity during primary HIV infection. AIDS. 2015 Feb 20; 29(4):433-42. Wright PW, Vaida FF, Fernández RJ, Rutlin J, Price RW, Lee E, Peterson J, Fuchs D, Shimony JS, Robertson KR, Walter R, Meyerhoff DJ, Spudich S, Ances BM. PMID: 25513818.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    43. Deep sequencing of HIV-1 variants from paired plasma and cerebrospinal fluid during primary HIV infection. J Virus Erad. 2015; 1(4):264-268. Gega A, Kozal MJ, Chiarella J, Lee E, Peterson J, Hecht FM, Liegler T, St John EP, Simen BB, Price RW, Spudich SS. PMID: 26855971.
      View in: PubMed   Mentions:
    44. Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection. PLoS One. 2014; 9(12):e116081. Peterson J, Gisslen M, Zetterberg H, Fuchs D, Shacklett BL, Hagberg L, Yiannoutsos CT, Spudich SS, Price RW. PMID: 25541953.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCells
    45. Progressive increase in central nervous system immune activation in untreated primary HIV-1 infection. J Neuroinflammation. 2014 Dec 03; 11:199. Suh J, Sinclair E, Peterson J, Lee E, Kyriakides TC, Li FY, Hagberg L, Fuchs D, Price RW, Gisslen M, Spudich S. PMID: 25465205.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    46. Effect of CD4+ cell count and viral suppression on risk of ischemic stroke in HIV infection. AIDS. 2014 Nov 13; 28(17):2573-7. Chow FC, Bacchetti P, Kim AS, Price RW, Hsue PY. PMID: 25160935.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    47. Cerebral metabolite changes prior to and after antiretroviral therapy in primary HIV infection. Neurology. 2014 Oct 28; 83(18):1592-600. Young AC, Yiannoutsos CT, Hegde M, Lee E, Peterson J, Walter R, Price RW, Meyerhoff DJ, Spudich S. PMID: 25261502.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    48. Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune activation. AIDS. 2014 Sep 24; 28(15):2251-8. Dahl V, Peterson J, Fuchs D, Gisslen M, Palmer S, Price RW. PMID: 25022595.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansCells
    49. Peripheral neuropathy in primary HIV infection associates with systemic and central nervous system immune activation. . 2014 Jul 01; 66(3):303-10. Wang SX, Ho EL, Grill M, Lee E, Peterson J, Robertson K, Fuchs D, Sinclair E, Price RW, Spudich S. PMID: 24732871.
      View in: PubMed   Mentions:
    50. Longitudinal characterization of depression and mood states beginning in primary HIV infection. AIDS Behav. 2014 Jun; 18(6):1124-32. Gold JA, Grill M, Peterson J, Pilcher C, Lee E, Hecht FM, Fuchs D, Yiannoutsos CT, Price RW, Robertson K, Spudich S. PMID: 24385231.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    51. Evolving character of chronic central nervous system HIV infection. Semin Neurol. 2014 Feb; 34(1):7-13. Price RW, Spudich SS, Peterson J, Joseph S, Fuchs D, Zetterberg H, Gisslén M, Swanstrom R. PMID: 24715483.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    52. Biomarker evidence of axonal injury in neuroasymptomatic HIV-1 patients. PLoS One. 2014; 9(2):e88591. Jessen Krut J, Mellberg T, Price RW, Hagberg L, Fuchs D, Rosengren L, Nilsson S, Zetterberg H, Gisslén M. PMID: 24523921.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansCells
    53. Central nervous system HIV-1 infection. Handb Clin Neurol. 2014; 123:487-505. Grill MF, Price RW. PMID: 25015501.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    54. An example of genetically distinct HIV type 1 variants in cerebrospinal fluid and plasma during suppressive therapy. J Infect Dis. 2014 May 15; 209(10):1618-22. Dahl V, Gisslen M, Hagberg L, Peterson J, Shao W, Spudich S, Price RW, Palmer S. PMID: 24338353.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    55. Is it time to rethink how neuropsychological tests are used to diagnose mild forms of HIV-associated neurocognitive disorders? Impact of false-positive rates on prevalence and power. Neuroepidemiology. 2013; 41(3-4):208-16. Meyer AC, Boscardin WJ, Kwasa JK, Price RW. PMID: 24157541.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    56. Screening for HIV-associated peripheral neuropathy in resource-limited settings. Muscle Nerve. 2013 Oct; 48(4):516-24. Cettomai D, Kwasa JK, Birbeck GL, Price RW, Cohen CR, Bukusi EA, Kendi C, Meyer AC. PMID: 24037693.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    57. Improved neurocognitive test performance in both arms of the SMART study: impact of practice effect. J Neurovirol. 2013 Aug; 19(4):383-92. Grund B, Wright EJ, Brew BJ, Price RW, Roediger MP, Bain MP, Hoy JF, Shlay JC, Vjecha MJ, Robertson KR, INSIGHT SMART Study Group . PMID: 23943468.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    58. Approach to cerebrospinal fluid (CSF) biomarker discovery and evaluation in HIV infection. J Neuroimmune Pharmacol. 2013 Dec; 8(5):1147-58. Price RW, Peterson J, Fuchs D, Angel TE, Zetterberg H, Hagberg L, Spudich S, Smith RD, Jacobs JM, Brown JN, Gisslen M. PMID: 23943280.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    59. Cellular Composition of Cerebrospinal Fluid in HIV-1 Infected and Uninfected Subjects. PLoS One. 2013; 8(6):e66188. Ho EL, Ronquillo R, Altmeppen H, Spudich SS, Price RW, Sinclair E. PMID: 23822975.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    60. Cerebrospinal fluid neopterin decay characteristics after initiation of antiretroviral therapy. J Neuroinflammation. 2013 May 10; 10:62. Yilmaz A, Yiannoutsos CT, Fuchs D, Price RW, Crozier K, Hagberg L, Spudich S, Gisslén M. PMID: 23664008.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    61. Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient. PLoS Pathog. 2013; 9(5):e1003347. Yukl SA, Boritz E, Busch M, Bentsen C, Chun TW, Douek D, Eisele E, Haase A, Ho YC, Hütter G, Justement JS, Keating S, Lee TH, Li P, Murray D, Palmer S, Pilcher C, Pillai S, Price RW, Rothenberger M, Schacker T, Siliciano J, Siliciano R, Sinclair E, Strain M, Wong J, Richman D, Deeks SG. PMID: 23671416.
      View in: PubMed   Mentions: 128     Fields:    Translation:HumansCellsCTClinical Trials
    62. Single-copy assay quantification of HIV-1 RNA in paired cerebrospinal fluid and plasma samples from elite controllers. AIDS. 2013 Apr 24; 27(7):1145-9. Dahl V, Peterson J, Spudich S, Lee E, Shacklett BL, Price RW, Palmer S. PMID: 23211774.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    63. Cerebrospinal fluid and neuroimaging biomarker abnormalities suggest early neurological injury in a subset of individuals during primary HIV infection. J Infect Dis. 2013 Jun 01; 207(11):1703-12. Peluso MJ, Meyerhoff DJ, Price RW, Peterson J, Lee E, Young AC, Walter R, Fuchs D, Brew BJ, Cinque P, Robertson K, Hagberg L, Zetterberg H, Gisslén M, Spudich S. PMID: 23460748.
      View in: PubMed   Mentions: 78     Fields:    Translation:Humans
    64. Cerebrospinal fluid Alzheimer's biomarker profiles in CNS infections. J Neurol. 2013 Feb; 260(2):620-6. Krut JJ, Zetterberg H, Blennow K, Cinque P, Hagberg L, Price RW, Studahl M, Gisslén M. PMID: 23052602.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCells
    65. Targeting chronic central nervous system HIV infection. Antivir Ther. 2012; 17(7):1227-31. Price RW, Swanstrom R. PMID: 23018178.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    66. Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load. AIDS. 2012 Sep 10; 26(14):1765-74. Peluso MJ, Ferretti F, Peterson J, Lee E, Fuchs D, Boschini A, Gisslén M, Angoff N, Price RW, Cinque P, Spudich S. PMID: 22614889.
      View in: PubMed   Mentions: 100     Fields:    Translation:HumansCells
    67. Cerebrospinal fluid-based kinetic biomarkers of axonal transport in monitoring neurodegeneration. J Clin Invest. 2012 Sep; 122(9):3159-69. Fanara P, Wong PY, Husted KH, Liu S, Liu VM, Kohlstaedt LA, Riiff T, Protasio JC, Boban D, Killion S, Killian M, Epling L, Sinclair E, Peterson J, Price RW, Cabin DE, Nussbaum RL, Brühmann J, Brandt R, Christine CW, Aminoff MJ, Hellerstein MK. PMID: 22922254.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimalsCells
    68. The cerebrospinal fluid proteome in HIV infection: change associated with disease severity. Clin Proteomics. 2012 Mar 20; 9(1):3. Angel TE, Jacobs JM, Spudich SS, Gritsenko MA, Fuchs D, Liegler T, Zetterberg H, Camp DG, Price RW, Smith RD. PMID: 22433316.
      View in: PubMed   Mentions:
    69. Lessons learned developing a diagnostic tool for HIV-associated dementia feasible to implement in resource-limited settings: pilot testing in Kenya. PLoS One. 2012; 7(3):e32898. Kwasa J, Cettomai D, Lwanya E, Osiemo D, Oyaro P, Birbeck GL, Price RW, Bukusi EA, Cohen CR, Meyer AC. PMID: 22412945.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    70. The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence? BMC Infect Dis. 2011 Dec 28; 11:356. Gisslén M, Price RW, Nilsson S. PMID: 22204557.
      View in: PubMed   Mentions: 76     Fields:    Translation:Humans
    71. Antiretroviral drug treatment of CNS HIV-1 infection. J Antimicrob Chemother. 2012 Feb; 67(2):299-311. Yilmaz A, Price RW, Gisslén M. PMID: 22160207.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    72. Raltegravir treatment intensification does not alter cerebrospinal fluid HIV-1 infection or immunoactivation in subjects on suppressive therapy. J Infect Dis. 2011 Dec 15; 204(12):1936-45. Dahl V, Lee E, Peterson J, Spudich SS, Leppla I, Sinclair E, Fuchs D, Palmer S, Price RW. PMID: 22021620.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCells
    73. HIV-1 replication in the central nervous system occurs in two distinct cell types. PLoS Pathog. 2011 Oct; 7(10):e1002286. Schnell G, Joseph S, Spudich S, Price RW, Swanstrom R. PMID: 22007152.
      View in: PubMed   Mentions: 116     Fields:    Translation:HumansCells
    74. Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden. J Infect Dis. 2011 Sep 01; 204(5):753-60. Spudich S, Gisslen M, Hagberg L, Lee E, Liegler T, Brew B, Fuchs D, Tambussi G, Cinque P, Hecht FM, Price RW. PMID: 21844301.
      View in: PubMed   Mentions: 77     Fields:    Translation:HumansCells
    75. A multinational study of neurological performance in antiretroviral therapy-naïve HIV-1-infected persons in diverse resource-constrained settings. J Neurovirol. 2011 Oct; 17(5):438-47. Robertson K, Kumwenda J, Supparatpinyo K, Jiang JH, Evans S, Campbell TB, Price RW, Murphy R, Hall C, Marra CM, Marcus C, Berzins B, Masih R, Santos B, Silva MT, Kumarasamy N, Walawander A, Nair A, Tripathy S, Kanyama C, Hosseinipour M, Montano S, La Rosa A, Amod F, Sanne I, Firnhaber C, Hakim J, Brouwers P, AIDS Clinical Trials Group . PMID: 21786076.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    76. Training needs and evaluation of a neuro-HIV training module for non-physician healthcare workers in western Kenya. J Neurol Sci. 2011 Aug 15; 307(1-2):92-6. Cettomai D, Kwasa J, Birbeck GL, Price RW, Bukusi EA, Meyer AC. PMID: 21652049.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    77. Minocycline fails to modulate cerebrospinal fluid HIV infection or immune activation in chronic untreated HIV-1 infection: results of a pilot study. AIDS Res Ther. 2011 May 12; 8:17. Ho EL, Spudich SS, Lee E, Fuchs D, Sinclair E, Price RW. PMID: 21569420.
      View in: PubMed   Mentions: 10     Fields:    
    78. Impact of antiretroviral therapy on HIV-related brain injury. Clin Infect Dis. 2011 Jan 15; 52(2):244-7. Price RW. PMID: 21288851.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    79. Utility of quantitative sensory testing and screening tools in identifying HIV-associated peripheral neuropathy in Western Kenya: pilot testing. PLoS One. 2010 Dec 08; 5(12):e14256. Cettomai D, Kwasa J, Kendi C, Birbeck GL, Price RW, Bukusi EA, Cohen CR, Meyer AC. PMID: 21170387.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    80. HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment. J Infect Dis. 2010 Dec 15; 202(12):1819-25. Edén A, Fuchs D, Hagberg L, Nilsson S, Spudich S, Svennerholm B, Price RW, Gisslén M. PMID: 21050119.
      View in: PubMed   Mentions: 114     Fields:    Translation:HumansCells
    81. Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons. Neurology. 2010 Sep 07; 75(10):864-73. Wright EJ, Grund B, Robertson K, Brew BJ, Roediger M, Bain MP, Drummond F, Vjecha MJ, Hoy J, Miller C, Penalva de Oliveira AC, Pumpradit W, Shlay JC, El-Sadr W, Price RW, INSIGHT SMART Study Group . PMID: 20702792.
      View in: PubMed   Mentions: 74     Fields:    Translation:Humans
    82. Development of diagnostic criteria for serious non-AIDS events in HIV clinical trials. HIV Clin Trials. 2010 Jul-Aug; 11(4):205-19. Lifson AR, INSIGHT Endpoint Review Committee Writing Group , Belloso WH, Davey RT, Duprez D, Gatell JM, Hoy JF, Krum EA, Nelson R, Pedersen C, Perez G, Price RW, Prineas RJ, Rhame FS, Sampson JH, Worley J, INSIGHT Study Group . PMID: 20974576.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    83. Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection. AIDS Res Ther. 2010 Jun 03; 7:15. Hagberg L, Cinque P, Gisslen M, Brew BJ, Spudich S, Bestetti A, Price RW, Fuchs D. PMID: 20525234.
      View in: PubMed   Mentions: 91     Fields:    
    84. Cerebrospinal fluid in HIV-1 systemic viral controllers: absence of HIV-1 RNA and intrathecal inflammation. AIDS. 2010 Apr 24; 24(7):1001-5. Probasco JC, Deeks SG, Lee E, Hoh R, Hunt PW, Liegler T, Price RW, Spudich SS. PMID: 20299968.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    85. Amyloid and tau cerebrospinal fluid biomarkers in HIV infection. BMC Neurol. 2009 Dec 22; 9:63. Gisslén M, Krut J, Andreasson U, Blennow K, Cinque P, Brew BJ, Spudich S, Hagberg L, Rosengren L, Price RW, Zetterberg H. PMID: 20028512.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansCells
    86. Compartmentalization and clonal amplification of HIV-1 variants in the cerebrospinal fluid during primary infection. J Virol. 2010 Mar; 84(5):2395-407. Schnell G, Price RW, Swanstrom R, Spudich S. PMID: 20015984.
      View in: PubMed   Mentions: 92     Fields:    Translation:HumansCells
    87. Broad screening for human herpesviridae DNA in multiple sclerosis cerebrospinal fluid and serum. Acta Neurol Belg. 2009 Dec; 109(4):277-82. Franciotta D, Bestetti A, Sala S, Perucca P, Jarius S, Price RW, Di Stefano AL, Cinque P. PMID: 20120207.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    88. Progressive multifocal leukoencephalopathy in HIV-1 infection. Lancet Infect Dis. 2009 Oct; 9(10):625-36. Cinque P, Koralnik IJ, Gerevini S, Miro JM, Price RW. PMID: 19778765.
      View in: PubMed   Mentions: 64     Fields:    Translation:HumansCells
    89. Raltegravir cerebrospinal fluid concentrations in HIV-1 infection. PLoS One. 2009 Sep 01; 4(9):e6877. Yilmaz A, Gisslén M, Spudich S, Lee E, Jayewardene A, Aweeka F, Price RW. PMID: 19721718.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCells
    90. Cross-sectional characterization of HIV-1 env compartmentalization in cerebrospinal fluid over the full disease course. AIDS. 2009 May 15; 23(8):907-15. Harrington PR, Schnell G, Letendre SL, Ritola K, Robertson K, Hall C, Burch CL, Jabara CB, Moore DT, Ellis RJ, Price RW, Swanstrom R. PMID: 19414991.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansCells
    91. Compartmentalized human immunodeficiency virus type 1 originates from long-lived cells in some subjects with HIV-1-associated dementia. PLoS Pathog. 2009 Apr; 5(4):e1000395. Schnell G, Spudich S, Harrington P, Price RW, Swanstrom R. PMID: 19390619.
      View in: PubMed   Mentions: 76     Fields:    Translation:HumansCells
    92. Darunavir concentrations in cerebrospinal fluid and blood in HIV-1-infected individuals. AIDS Res Hum Retroviruses. 2009 Apr; 25(4):457-61. Yilmaz A, Izadkhashti A, Price RW, Mallon PW, De Meulder M, Timmerman P, Gisslén M. PMID: 19320601.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    93. Major coexisting human immunodeficiency virus type 1 env gene subpopulations in the peripheral blood are produced by cells with similar turnover rates and show little evidence of genetic compartmentalization. J Virol. 2009 May; 83(9):4068-80. Ince WL, Harrington PR, Schnell GL, Patel-Chhabra M, Burch CL, Menezes P, Price RW, Eron JJ, Swanstrom RI. PMID: 19211740.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    94. OTK18 levels in plasma and cerebrospinal fluid correlate with viral load and CD8 T-cells in normal and AIDS patients. J Neuroimmune Pharmacol. 2008 Dec; 3(4):230-5. Buescher JL, Duan F, Sun J, Price RW, Ikezu T. PMID: 18773297.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    95. Failure of atorvastatin to modulate CSF HIV-1 infection: results of a pilot study. Neurology. 2008 Aug 12; 71(7):521-4. Probasco JC, Spudich SS, Critchfield J, Lee E, Lollo N, Deeks SG, Price RW. PMID: 18695163.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCellsCTClinical Trials
    96. Antiretroviral therapy and central nervous system HIV type 1 infection. J Infect Dis. 2008 May 15; 197 Suppl 3:S294-306. Price RW, Spudich S. PMID: 18447615.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansCells
    97. Determination of the underlying cause of death in three multicenter international HIV clinical trials. HIV Clin Trials. 2008 May-Jun; 9(3):177-85. Lifson AR, INSIGHT Cause of Death Writing Group , Belloso WH, Carey C, Davey RT, Duprez D, El-Sadr WM, Gatell JM, Gey DC, Hoy JF, Krum EA, Nelson R, Nixon DE, Paton N, Pedersen C, Perez G, Price RW, Prineas RJ, Rhame FS, Sampson J, Worley J. PMID: 18547904.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    98. Antiretroviral treatment effect on immune activation reduces cerebrospinal fluid HIV-1 infection. . 2008 Apr 15; 47(5):544-52. Sinclair E, Ronquillo R, Lollo N, Deeks SG, Hunt P, Yiannoutsos CT, Spudich S, Price RW. PMID: 18362693.
      View in: PubMed   Mentions:
    99. Persistent intrathecal immune activation in HIV-1-infected individuals on antiretroviral therapy. . 2008 Feb 01; 47(2):168-73. Yilmaz A, Price RW, Spudich S, Fuchs D, Hagberg L, Gisslén M. PMID: 17971711.
      View in: PubMed   Mentions:
    100. Enfuvirtide cerebrospinal fluid (CSF) pharmacokinetics and potential use in defining CSF HIV-1 origin. Antivir Ther. 2008; 13(3):369-74. Price RW, Parham R, Kroll JL, Wring SA, Baker B, Sailstad J, Hoh R, Liegler T, Spudich S, Kuritzkes DR, Deeks SG. PMID: 18572749.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    101. Immune activation of the central nervous system is still present after >4 years of effective highly active antiretroviral therapy. J Infect Dis. 2007 Dec 15; 196(12):1779-83. Edén A, Price RW, Spudich S, Fuchs D, Hagberg L, Gisslén M. PMID: 18190258.
      View in: PubMed   Mentions: 95     Fields:    Translation:HumansCells
    102. Biomarkers of HIV-1 CNS infection and injury. Neurology. 2007 Oct 30; 69(18):1781-8. Price RW, Epstein LG, Becker JT, Cinque P, Gisslen M, Pulliam L, McArthur JC. PMID: 17967994.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCells
    103. Antiretroviral treatment reduces increased CSF neurofilament protein (NFL) in HIV-1 infection. Neurology. 2007 Oct 09; 69(15):1536-41. Mellgren A, Price RW, Hagberg L, Rosengren L, Brew BJ, Gisslén M. PMID: 17923616.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCells
    104. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007 Oct 30; 69(18):1789-99. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE. PMID: 17914061.
      View in: PubMed   Mentions: 1128     Fields:    Translation:HumansCells
    105. Elevated cerebrospinal fluid neurofilament light protein concentrations predict the development of AIDS dementia complex. J Infect Dis. 2007 Jun 15; 195(12):1774-8. Gisslen M, Hagberg L, Brew BJ, Cinque P, Price RW, Rosengren L. PMID: 17492593.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCells
    106. CSF neurofilament protein (NFL) -- a marker of active HIV-related neurodegeneration. J Neurol. 2007 Aug; 254(8):1026-32. Abdulle S, Mellgren A, Brew BJ, Cinque P, Hagberg L, Price RW, Rosengren L, Gisslén M. PMID: 17420923.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCells
    107. Factors in AIDS dementia complex trial design: results and lessons from the abacavir trial. PLoS Clin Trials. 2007 Mar 30; 2(3):e13. Brew BJ, Halman M, Catalan J, Sacktor N, Price RW, Brown S, Atkinson H, Clifford DB, Simpson D, Torres G, Hall C, Power C, Marder K, Mc Arthur JC, Symonds W, Romero C. PMID: 17401456.
      View in: PubMed   Mentions:
    108. Cerebrospinal fluid markers in central nervous system HIV infection and AIDS dementia complex. Handb Clin Neurol. 2007; 85:261-300. Cinque P, Brew BJ, Gisslen M, Hagberg L, Price RW. PMID: 18808988.
      View in: PubMed   Mentions: 13     Fields:    
    109. Treatment benefit on cerebrospinal fluid HIV-1 levels in the setting of systemic virological suppression and failure. J Infect Dis. 2006 Dec 15; 194(12):1686-96. Spudich S, Lollo N, Liegler T, Deeks SG, Price RW. PMID: 17109340.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCells
    110. Editorial comment: AIDS dementia complex in the current era. AIDS Read. 2006 Nov; 16(11):630-1. Price RW. PMID: 17152650.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    111. Timed Gait test: normative data for the assessment of the AIDS dementia complex. J Clin Exp Neuropsychol. 2006 Oct; 28(7):1053-64. Robertson KR, Parsons TD, Sidtis JJ, Hanlon Inman T, Robertson WT, Hall CD, Price RW. PMID: 16840235.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    112. Defining and evaluating HIV-related neurodegenerative disease and its treatment targets: a combinatorial approach to use of cerebrospinal fluid molecular biomarkers. J Neuroimmune Pharmacol. 2007 Mar; 2(1):112-9. Gisslen M, Hagberg L, Rosengren L, Brew BJ, Cinque P, Spudich S, Price RW. PMID: 18040834.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimals
    113. Prevalence of CXCR4 tropism among antiretroviral-treated HIV-1-infected patients with detectable viremia. J Infect Dis. 2006 Oct 01; 194(7):926-30. Hunt PW, Harrigan PR, Huang W, Bates M, Williamson DW, McCune JM, Price RW, Spudich SS, Lampiris H, Hoh R, Leigler T, Martin JN, Deeks SG. PMID: 16960780.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansCellsCTClinical Trials
    114. Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment. BMC Infect Dis. 2005 Nov 02; 5:98. Spudich SS, Nilsson AC, Lollo ND, Liegler TJ, Petropoulos CJ, Deeks SG, Paxinos EE, Price RW. PMID: 16266436.
      View in: PubMed   Mentions: 72     Fields:    Translation:HumansCells
    115. Enrichment of activated monocytes in cerebrospinal fluid during antiretroviral therapy. AIDS. 2005 Sep 02; 19(13):1351-9. Neuenburg JK, Furlan S, Bacchetti P, Price RW, Grant RM. PMID: 16103765.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    116. Cerebrospinal fluid signs of neuronal damage after antiretroviral treatment interruption in HIV-1 infection. AIDS Res Ther. 2005 Aug 18; 2:6. Gisslén M, Rosengren L, Hagberg L, Deeks SG, Price RW. PMID: 16109178.
      View in: PubMed   Mentions: 19     Fields:    
    117. Cerebrospinal fluid interferon-gamma-inducible protein 10 (IP-10, CXCL10) in HIV-1 infection. J Neuroimmunol. 2005 Nov; 168(1-2):154-63. Cinque P, Bestetti A, Marenzi R, Sala S, Gisslen M, Hagberg L, Price RW. PMID: 16091292.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCells
    118. Undetectable cerebrospinal fluid HIV RNA and beta-2 microglobulin do not indicate inactive AIDS dementia complex in highly active antiretroviral therapy-treated patients. . 2005 Aug 01; 39(4):426-9. Cysique LA, Brew BJ, Halman M, Catalan J, Sacktor N, Price RW, Brown S, Atkinson JH, Clifford DB, Simpson D, Torres G, Hall C, Power C, Marder K, McArthur JC, Symonds W, Romero C. PMID: 16010165.
      View in: PubMed   Mentions:
    119. T-cell activation and memory phenotypes in cerebrospinal fluid during HIV infection. . 2005 May 01; 39(1):16-22. Neuenburg JK, Cho TA, Nilsson A, Bredt BM, Hebert SJ, Grant RM, Price RW. PMID: 15851909.
      View in: PubMed   Mentions:
    120. Editorial comment: déjà vu--neurologic complications of HIV infection in the expanding epidemic. AIDS Read. 2005 Mar; 15(3):144. Price RW, Robertson K. PMID: 15786578.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    121. HIV-1 chemokine coreceptor utilization in paired cerebrospinal fluid and plasma samples: a survey of subjects with viremia. J Infect Dis. 2005 Mar 15; 191(6):890-8. Spudich SS, Huang W, Nilsson AC, Petropoulos CJ, Liegler TJ, Whitcomb JM, Price RW. PMID: 15717264.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCellsCTClinical Trials
    122. Cerebrospinal fluid HIV-1 infection usually responds well to antiretroviral treatment. Antivir Ther. 2005; 10(6):701-7. Mellgren A, Antinori A, Cinque P, Price RW, Eggers C, Hagberg L, Gisslén M. PMID: 16218168.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCellsCTClinical Trials
    123. Neurological complications of HIV infection and AIDS: current and future perspectives. J Neurovirol. 2005; 11 Suppl 3:1-5. Cinque P, Robertson K, Antinori A, Price RW. PMID: 16540446.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    124. Expression of the urokinase plasminogen activator and its receptor in HIV-1-associated central nervous system disease. J Neuroimmunol. 2004 Dec; 157(1-2):133-9. Sidenius N, Nebuloni M, Sala S, Zerbi P, Price RW, Gisslen M, Hagberg L, Vago L, Lazzarin A, Blasi F, Cinque P. PMID: 15579290.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    125. HIV-producing T cells in cerebrospinal fluid. . 2004 Oct 01; 37(2):1237-44. Neuenburg JK, Sinclair E, Nilsson A, Kreis C, Bacchetti P, Price RW, Grant RM. PMID: 15385730.
      View in: PubMed   Mentions:
    126. Chemokine receptors, neural progenitor cells, and the AIDS dementia complex. J Infect Dis. 2004 Jul 15; 190(2):211-5. Kao AW, Price RW. PMID: 15216453.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    127. Increased adhesion molecule and chemokine receptor expression on CD8+ T cells trafficking to cerebrospinal fluid in HIV-1 infection. J Infect Dis. 2004 Jun 15; 189(12):2202-12. Shacklett BL, Cox CA, Wilkens DT, Karl Karlsson R, Nilsson A, Nixon DF, Price RW. PMID: 15181567.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCells
    128. The urokinase receptor is overexpressed in the AIDS dementia complex and other neurological manifestations. Ann Neurol. 2004 May; 55(5):687-94. Cinque P, Nebuloni M, Santovito ML, Price RW, Gisslen M, Hagberg L, Bestetti A, Vago G, Lazzarin A, Blasi F, Sidenius N. PMID: 15122709.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    129. CSF quinolinic acid levels are determined by local HIV infection: cross-sectional analysis and modelling of dynamics following antiretroviral therapy. Brain. 2004 May; 127(Pt 5):1047-60. Valle M, Price RW, Nilsson A, Heyes M, Verotta D. PMID: 15013955.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    130. Antiretroviral drug treatment interruption in human immunodeficiency virus-infected adults: Clinical and pathogenetic implications for the central nervous system. J Neurovirol. 2004; 10 Suppl 1:44-51. Price RW, Deeks SG. PMID: 14982739.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    131. Editorial comment: diagnosis of focal brain lesions--old lessons retaught. AIDS Read. 2003 Nov; 13(11):553. Price RW. PMID: 14649626.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    132. HIV-related neuropathology, 1985 to 1999: rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy. . 2002 Oct 01; 31(2):171-7. Neuenburg JK, Brodt HR, Herndier BG, Bickel M, Bacchetti P, Price RW, Grant RM, Schlote W. PMID: 12394795.
      View in: PubMed   Mentions:
    133. A pilot study of the discontinuation of antifungal therapy for disseminated cryptococcal disease in patients with acquired immunodeficiency syndrome, following immunologic response to antiretroviral therapy. J Infect Dis. 2002 Apr 15; 185(8):1179-82. Aberg JA, Price RW, Heeren DM, Bredt B. PMID: 11930330.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    134. Screening for the AIDS dementia complex. AIDS Read. 2002 Jan; 12(1):32-3. Price RW. PMID: 11862659.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    135. Cerebrospinal fluid response to structured treatment interruption after virological failure. AIDS. 2001 Jul 06; 15(10):1251-9. Price RW, Paxinos EE, Grant RM, Drews B, Nilsson A, Hoh R, Hellmann NS, Petropoulos CJ, Deeks SG. PMID: 11426069.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    136. HIV-1 reverse transcriptase sequence in plasma and cerebrospinal fluid of patients with AIDS dementia complex treated with Abacavir. AIDS. 2001 Apr 13; 15(6):747-51. Lanier ER, Sturge G, McClernon D, Brown S, Halman M, Sacktor N, McArthur J, Atkinson JH, Clifford D, Price RW, Simpson D, Torres G, Catalan J, Marder K, Power C, Hall C, Romero C, Brew B. PMID: 11371689.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCellsCTClinical Trials
    137. The two faces of HIV infection of cerebrospinal fluid. Trends Microbiol. 2000 Sep; 8(9):387-91. Price RW. PMID: 10989300.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimals
    138. Kaposi's sarcoma and central nervous system disease: a real association or an artifact of the control group? Terry Beirn Community Programs for Clinical Research on AIDS. AIDS. 2000 May 26; 14(8):995-1000. Eberly LE, Ohman PA, Neaton JD, Price RW, Abrams DI. PMID: 10853981.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    139. Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy. AIDS Clinical Trial Group and Neurological AIDS Research Consortium study team. AIDS. 1999 Sep 10; 13(13):1677-85. Price RW, Yiannoutsos CT, Clifford DB, Zaborski L, Tselis A, Sidtis JJ, Cohen B, Hall CD, Erice A, Henry K. PMID: 10509569.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCellsCTClinical Trials
    140. Time course of cerebrospinal fluid responses to antiretroviral therapy: evidence for variable compartmentalization of infection. AIDS. 1999 Jun 18; 13(9):1051-61. Staprans S, Marlowe N, Glidden D, Novakovic-Agopian T, Grant RM, Heyes M, Aweeka F, Deeks S, Price RW. PMID: 10397535.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCells
    141. Failure to detect nelfinavir in the cerebrospinal fluid of HIV-1--infected patients with and without AIDS dementia complex. J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Jan 01; 20(1):39-43. Aweeka F, Jayewardene A, Staprans S, Bellibas SE, Kearney B, Lizak P, Novakovic-Agopian T, Price RW. PMID: 9928728.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    142. Experience with a cross-study endpoint review committee for AIDS clinical trials. Terry Beirn Community Programs for Clinical Research on AIDS. AIDS. 1998 Oct 22; 12(15):1983-90. Green LA, Rhame FS, Price RW, Perlman DC, Capps LG, Sampson JH, Deyton LR, Schnittman SM, Fisher EJ, Bartsch GE, Krum EA, Neaton JD. PMID: 9814866.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    143. Neuropathy complicating diffuse infiltrative lymphocytosis. Lancet. 1998 Aug 22; 352(9128):592-4. Price RW. PMID: 9746016.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    144. Stable neurological function in subjects treated with 2'3'-dideoxyinosine. J Neurovirol. 1997 Jun; 3(3):233-40. Sidtis JJ, Dafni U, Slasor P, Hall C, Price RW, Kieburtz K, Tucker T, Clifford DB. PMID: 9200072.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    145. Neurological complications of HIV infection. Lancet. 1996 Aug 17; 348(9025):445-52. Price RW. PMID: 8709786.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    146. Abnormal cerebral glucose metabolism in HIV-1 seropositive subjects with and without dementia. J Nucl Med. 1996 Jul; 37(7):1133-41. Rottenberg DA, Sidtis JJ, Strother SC, Schaper KA, Anderson JR, Nelson MJ, Price RW. PMID: 8965184.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCells
    147. Managing HIV. Part 3: Mechanisms of diseases. 3.7 How HIV leads to neurological disease. Med J Aust. 1996 Feb 19; 164(4):233-4. Brew BJ, Wesselingh SL, Gonzales M, Heyes MP, Price RW. PMID: 8604196.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    148. The cellular basis of central nervous system HIV-1 infection and the AIDS dementia complex: introduction. J NeuroAIDS. 1996; 1(1):1-29. Price RW. PMID: 16873153.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    149. AIDS dementia complex: a complex, slow virus "model" of acquired genetic neurodegenerative disease. Cold Spring Harb Symp Quant Biol. 1996; 61:759-70. Price RW. PMID: 9246501.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    150. AIDS dementia complex and HIV-1 brain infection: clinical-virological correlations. Ann Neurol. 1995 Oct; 38(4):563-70. Brew BJ, Rosenblum M, Cronin K, Price RW. PMID: 7574452.
      View in: PubMed   Mentions: 68     Fields:    Translation:HumansCells
    151. Management of AIDS dementia complex and HIV-1 infection of the nervous system. AIDS. 1995; 9 Suppl A:S221-36. Price RW. PMID: 8819589.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    152. AIDS dementia complex and HIV-1 brain infection: a pathogenetic framework for treatment and evaluation. Curr Top Microbiol Immunol. 1995; 202:33-54. Price RW. PMID: 7587369.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    153. Cerebrospinal fluid HIV-1 p24 antigen and culture: sensitivity and specificity for AIDS-dementia complex. J Neurol Neurosurg Psychiatry. 1994 Jul; 57(7):784-9. Brew BJ, Paul MO, Nakajima G, Khan A, Gallardo H, Price RW. PMID: 8021661.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    154. Zidovudine treatment of the AIDS dementia complex: results of a placebo-controlled trial. AIDS Clinical Trials Group. Ann Neurol. 1993 Apr; 33(4):343-9. Sidtis JJ, Gatsonis C, Price RW, Singer EJ, Collier AC, Richman DD, Hirsch MS, Schaerf FW, Fischl MA, Kieburtz K. PMID: 8489204.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansCTClinical Trials
    155. Complete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: evidence for limited defectiveness and complementation. J Virol. 1992 Nov; 66(11):6587-600. Li Y, Hui H, Burgess CJ, Price RW, Sharp PM, Hahn BH, Shaw GM. PMID: 1404605.
      View in: PubMed   Mentions: 93     Fields:    Translation:HumansCells
    156. Increased neopterin levels in brains of patients with human immunodeficiency virus type 1 infection. J Neurochem. 1992 Oct; 59(4):1541-6. Shaskan EG, Brew BJ, Rosenblum M, Thompson RM, Price RW. PMID: 1328524.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    157. Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and beta 2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients. J Neuroimmunol. 1992 Sep; 40(1):71-80. Heyes MP, Brew BJ, Saito K, Quearry BJ, Price RW, Lee K, Bhalla RB, Der M, Markey SP. PMID: 1387655.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCells
    158. Undetectable tumor necrosis factor-alpha in spinal fluid from HIV-1-infected patients. Ann Neurol. 1992 Jun; 31(6):687-9. Shaskan EG, Thompson RM, Price RW. PMID: 1514782.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    159. Cerebrospinal fluid beta 2-microglobulin in patients with AIDS dementia complex: an expanded series including response to zidovudine treatment. AIDS. 1992 May; 6(5):461-5. Brew BJ, Bhalla RB, Paul M, Sidtis JJ, Keilp JJ, Sadler AE, Gallardo H, McArthur JC, Schwartz MK, Price RW. PMID: 1616651.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    160. Human T-lymphotropic virus type I-associated myelopathy in patients with the acquired immunodeficiency syndrome. Hum Pathol. 1992 May; 23(5):513-9. Rosenblum MK, Brew BJ, Hahn B, Shaw G, Haase A, Maroushek S, Price RW. PMID: 1568747.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    161. Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo. J Virol. 1992 Apr; 66(4):2577-82. Westervelt P, Trowbridge DB, Epstein LG, Blumberg BM, Li Y, Hahn BH, Shaw GM, Price RW, Ratner L. PMID: 1548783.
      View in: PubMed   Mentions: 130     Fields:    Translation:HumansCells
    162. Pursuit eye movement dysfunction in HIV-1 seropositive individuals. J Psychiatry Neurosci. 1991 Dec; 16(5):247-52. Sweeney JA, Brew BJ, Keilp JG, Sidtis JJ, Price RW. PMID: 1797099.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    163. Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomes. J Virol. 1991 Aug; 65(8):3973-85. Li Y, Kappes JC, Conway JA, Price RW, Shaw GM, Hahn BH. PMID: 1830110.
      View in: PubMed   Mentions: 195     Fields:    Translation:HumansCells
    164. Herpes zoster myelitis. Brain. 1991 Jun; 114 ( Pt 3):1181-96. Devinsky O, Cho ES, Petito CK, Price RW. PMID: 1648419.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCells
    165. AIDS dementia complex and HIV-1 infection: a view from the clinic. Brain Pathol. 1991 Apr; 1(3):155-62. Price RW, Sidtis JJ, Brew BJ. PMID: 1669704.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    166. HTLV-I-associated myelopathy associated with blood transfusion in the United States: epidemiologic and molecular evidence linking donor and recipient. Neurology. 1991 Feb; 41(2 ( Pt 1)):192-7. Kaplan JE, Litchfield B, Rouault C, Lairmore MD, Luo CC, Williams L, Brew BJ, Price RW, Janssen R, Stoneburner R. PMID: 1992361.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    167. Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann Neurol. 1991 Feb; 29(2):202-9. Heyes MP, Brew BJ, Martin A, Price RW, Salazar AM, Sidtis JJ, Yergey JA, Mouradian MM, Sadler AE, Keilp J. PMID: 1826418.
      View in: PubMed   Mentions: 113     Fields:    Translation:HumansCells
    168. Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndrome. Adv Exp Med Biol. 1991; 294:687-90. Heyes MP, Brew B, Martin A, Markey SP, Price RW, Bhalla RB, Salazar A. PMID: 1837699.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    169. Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection. Ann Neurol. 1990 Oct; 28(4):556-60. Brew BJ, Bhalla RB, Paul M, Gallardo H, McArthur JC, Schwartz MK, Price RW. PMID: 2252366.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCells
    170. Early HIV-1 infection and the AIDS dementia complex. Neurology. 1990 Feb; 40(2):323-6. Sidtis JJ, Price RW. PMID: 2300258.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    171. The AIDS dementia complex and HIV-1 brain infection: a pathogenetic model of virus-immune interaction. Res Publ Assoc Res Nerv Ment Dis. 1990; 68:269-90. Price RW, Brew BJ, Rosenblum M. PMID: 2183316.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    172. Evaluation of the AIDS dementia complex in clinical trials. J Acquir Immune Defic Syndr (1988). 1990; 3 Suppl 2:S51-60. Price RW, Sidtis JJ. PMID: 2231303.
      View in: PubMed   Mentions:
    173. Dissociation of AIDS-related vacuolar myelopathy and productive HIV-1 infection of the spinal cord. Neurology. 1989 Jul; 39(7):892-6. Rosenblum M, Scheck AC, Cronin K, Brew BJ, Khan A, Paul M, Price RW. PMID: 2739916.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    174. Cerebrospinal fluid beta 2 microglobulin in patients infected with human immunodeficiency virus. Neurology. 1989 Jun; 39(6):830-4. Brew BJ, Bhalla RB, Fleisher M, Paul M, Khan A, Schwartz MK, Price RW. PMID: 2657485.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    175. Human immunodeficiency virus (HIV) infection and the nervous system: report from the American Academy of Neurology AIDS Task Force. Neurology. 1989 Jan; 39(1):119-22. Janssen RS, Cornblath DR, Epstein LG, McArthur J, Price RW. PMID: 2642609.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    176. AIDS dementia complex and primary HIV brain infection. J Neuroimmunol. 1988 Dec; 20(2-3):133-40. Brew BJ, Rosenblum M, Price RW. PMID: 3058741.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    177. The AIDS dementia complex. J Infect Dis. 1988 Nov; 158(5):1079-83. Price RW, Brew BJ. PMID: 3053922.
      View in: PubMed   Mentions: 100     Fields:    Translation:Humans
    178. AIDS dementia complex. J R Coll Physicians Lond. 1988 Jul; 22(3):140-4. Brew BJ, Sidtis JJ, Rosenblum M, Price RW. PMID: 3411540.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    179. Management of the neurologic complications of HIV infection and AIDS. Infect Dis Clin North Am. 1988 Jun; 2(2):359-72. Price RW, Brew B. PMID: 2849620.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    180. Another retroviral disease of the nervous system: chronic progressive myelopathy due to HTLV-1. N Engl J Med. 1988 May 05; 318(18):1195-7. Brew BJ, Price RW. PMID: 2896301.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    181. Neuropsychological characterization of the AIDS dementia complex: a preliminary report. AIDS. 1988 Apr; 2(2):81-8. Tross S, Price RW, Navia B, Thaler HT, Gold J, Hirsch DA, Sidtis JJ. PMID: 3132951.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    182. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science. 1988 Feb 05; 239(4840):586-92. Price RW, Brew B, Sidtis J, Rosenblum M, Scheck AC, Cleary P. PMID: 3277272.
      View in: PubMed   Mentions: 274     Fields:    Translation:Humans
    183. Infection of the central nervous system by human immunodeficiency virus. Role of the immune system in pathogenesis. Ann N Y Acad Sci. 1988; 540:162-75. Price RW, Brew B. PMID: 3061334.
      View in: PubMed   Mentions: 4     Fields:    Translation:Cells
    184. The management of the neurological complications of HIV infection and AIDS. AIDS. 1988; 2 Suppl 1:S151-9. Aronow HA, Brew BJ, Price RW. PMID: 3147665.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    185. Pathogenetic implications of neuropathological findings in the AIDS dementia complex. Psychopharmacol Bull. 1988; 24(3):307-10. Brew BJ, Rosenblum M, Price RW. PMID: 3153483.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    186. The metabolic pathology of the AIDS dementia complex. Ann Neurol. 1987 Dec; 22(6):700-6. Rottenberg DA, Moeller JR, Strother SC, Sidtis JJ, Navia BA, Dhawan V, Ginos JZ, Price RW. PMID: 3501695.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    187. HIV antigen in the brains of patients with the AIDS dementia complex. Ann Neurol. 1987 May; 21(5):490-6. Pumarola-Sune T, Navia BA, Cordon-Cardo C, Cho ES, Price RW. PMID: 3296948.
      View in: PubMed   Mentions: 73     Fields:    Translation:HumansCells
    188. 5-substituted 2'-fluoro-arabinonucleosides as potential antiviral agents. Nucleic Acids Symp Ser. 1987; (18):261-4. Huang JT, Schinazi RF, Gadler H, Price RW, Su TL, Watanabe KA. PMID: 2827131.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    189. The acquired immunodeficiency syndrome dementia complex as the presenting or sole manifestation of human immunodeficiency virus infection. Arch Neurol. 1987 Jan; 44(1):65-9. Navia BA, Price RW. PMID: 3800724.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    190. Neuropathology of acquired immunodeficiency syndrome (AIDS): an autopsy review. J Neuropathol Exp Neurol. 1986 Nov; 45(6):635-46. Petito CK, Cho ES, Lemann W, Navia BA, Price RW. PMID: 3021914.
      View in: PubMed   Mentions: 106     Fields:    Translation:Humans
    191. Confirmation of HTLV-III virus in cornea. Am J Ophthalmol. 1986 Sep 15; 102(3):390-1. Doro S, Navia BA, Kahn A, Pumarola-Sune T, Price RW. PMID: 3019144.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    192. The AIDS dementia complex: II. Neuropathology. Ann Neurol. 1986 Jun; 19(6):525-35. Navia BA, Cho ES, Petito CK, Price RW. PMID: 3014994.
      View in: PubMed   Mentions: 298     Fields:    Translation:HumansCells
    193. The AIDS dementia complex: I. Clinical features. Ann Neurol. 1986 Jun; 19(6):517-24. Navia BA, Jordan BD, Price RW. PMID: 3729308.
      View in: PubMed   Mentions: 298     Fields:    Translation:Humans
    194. Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: clinical and neuropathological findings in 27 patients. Ann Neurol. 1986 Mar; 19(3):224-38. Navia BA, Petito CK, Gold JW, Cho ES, Jordan BD, Price RW. PMID: 3963767.
      View in: PubMed   Mentions: 93     Fields:    Translation:Humans
    195. AIDS encephalopathy. Neurol Clin. 1986 Feb; 4(1):285-301. Price RW, Navia BA, Cho ES. PMID: 2425241.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    196. Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome. N Engl J Med. 1985 Apr 04; 312(14):874-9. Petito CK, Navia BA, Cho ES, Jordan BD, George DC, Price RW. PMID: 3974673.
      View in: PubMed   Mentions: 75     Fields:    Translation:HumansCells
    197. HTLV-III infection in brains of children and adults with AIDS encephalopathy. Science. 1985 Jan 11; 227(4683):177-82. Shaw GM, Harper ME, Hahn BH, Epstein LG, Gajdusek DC, Price RW, Navia BA, Petito CK, O'Hara CJ, Groopman JE. PMID: 2981429.
      View in: PubMed   Mentions: 177     Fields:    Translation:HumansCells
    198. Neurological syndromes complicating AIDS. Front Radiat Ther Oncol. 1985; 19:82-7. Jordan BD, Navia BA, Petito C, Cho ES, Price RW. PMID: 3979830.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    199. Enhanced regional uptake of 2-deoxy-D-[14C]glucose in focal herpes simplex type 1 encephalitis: autoradiographic study in the rat. Neurology. 1984 Mar; 34(3):276-84. Saito Y, Price RW. PMID: 6538267.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    200. HTLV-III/LAV-like retrovirus particles in the brains of patients with AIDS encephalopathy. AIDS Res. 1984-1985; 1(6):447-54. Epstein LG, Sharer LR, Cho ES, Myenhofer M, Navia B, Price RW. PMID: 6100783.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansCells
    201. Progressive multifocal leukoencephalopathy: a burnt-out case. Ann Neurol. 1983 May; 13(5):485-90. Price RW, Nielsen S, Horten B, Rubino M, Padgett B, Walker D. PMID: 6307116.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    202. Interferon protects neurons in culture infected with vesicular stomatitis and herpes simplex viruses. J Neurol Sci. 1982 Oct; 56(1):115-28. Tsukamoto LF, Price RW. PMID: 6183402.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    203. Progressive multifocal leukoencephalopathy (PML): in vitro cell-mediated immune responses to mitogens and JC virus. Neurology. 1980 Mar; 30(3):256-62. Willoughby E, Price RW, Padgett BL, Walker DL, Dupont B. PMID: 6987549.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    204. Effect of immunization on acute and latent infections of vaginouterine tissue with herpes simplex virus types 1 and 2. J Infect Dis. 1977 May; 135(5):744-52. Walz MA, Price RW, Hayashi K, Katz BJ, Notkins AL. PMID: 192810.
      View in: PubMed   Mentions: 24     Fields:    Translation:AnimalsCellsPHPublic Health
    Richard's Networks
    Concepts (509)
    Derived automatically from this person's publications.
    Co-Authors (53)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department